1. Home
  2. CODA vs HOWL Comparison

CODA vs HOWL Comparison

Compare CODA & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

N/A

Current Price

$12.11

Market Cap

155.4M

Sector

Industrials

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

N/A

Current Price

$0.80

Market Cap

30.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CODA
HOWL
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
30.7M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CODA
HOWL
Price
$12.11
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
373.3K
384.5K
Earning Date
03-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
15.62
N/A
EPS
0.08
N/A
Revenue
$20,316,161.00
N/A
Revenue This Year
$18.28
N/A
Revenue Next Year
$12.62
N/A
P/E Ratio
$147.69
N/A
Revenue Growth
4.98
N/A
52 Week Low
$5.76
$0.53
52 Week High
$18.00
$2.23

Technical Indicators

Market Signals
Indicator
CODA
HOWL
Relative Strength Index (RSI) 42.26 55.81
Support Level $7.80 $0.56
Resistance Level $12.22 $0.80
Average True Range (ATR) 1.15 0.08
MACD -0.44 0.01
Stochastic Oscillator 5.03 66.63

Price Performance

Historical Comparison
CODA
HOWL

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: